Usman Baber

Associate Professor of Medicine

University of Oklahoma Health Sciences Center

  • LinkedIn
  • X
  • OrcidID


Personal History

Dr. Usman Baber is a Cardiologist and an Interventional Cardiologist based in Oklahoma City, Oklahoma.1


Academic History

Dr. Baber earned his bachelor's degree in Biochemistry from Rice University in 1999 and graduated as a Doctor of Medicine from  UT Southwestern Medical Center in 2004. During his fellowship training he also earned a master’s degree in biostatistics from the Mailman School of Public Health at Columbia University in 2010.1


Career Overview

Dr. Baber is an Associate Professor of Medicine at the University of Oklahoma Health Sciences Center and serves as the Director of Interventional Cardiology and the Cardiac Catheterization Laboratory. Prior to joining the University of Oklahoma, Dr. Baber served as the Director of Cath Lab Quality and Outcomes Research within the Cardiovascular Institute at Mount Sinai Hospital in New York City.1

From a clinical standpoint Dr. Baber focuses on complex, high-risk coronary interventions. His research interests include clinical and translational projects related to bleeding, thrombosis and platelet function. Most recently Dr. Baber served as the Chair of the Clinical and Data Coordinating Center for the international, randomized TWILIGHT trial, which was published in the NEJM in 2019.1

He is a frequent lecturer at international cardiology conferences, serves on the Editorial Boards of numerous peer-reviewed journals and teaches clinical trial design and biostatistics for the interventional cardiology board review course sponsored by the American College of Cardiology.1


Career Timeline

  • 1995 - 1999: Bachelor’s Degree Biochemistry, Rice University
  • 2000 - 2004: Doctor of Medicine, UT Southwestern Medical Center
  • 2009 - 2010: Master of Science Biostatistics, Columbia University Mailman School of Public Health
  • 2011 - Present: Assistant Professor, Mount Sinai Medical Center



  • Cardiovascular Medicine American Board of Internal Medicine
  • Internal Medicine American Board of Internal Medicine
  • Interventional Cardiology American Board of Internal Medicine


Areas of Speciality





Articles by Usman Baber, Associate Professor of Medicine

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations

Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, et al


Citation: European Cardiology Review 2021;16:e43.

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention

Johny Nicolas, Usman Baber, Roxana Mehran, et al


Citation: US Cardiology Review 2020;14:e04.